Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz
Clover Health stock surged nearly 18% to about $3.79 on Oct. 24, with trading volume exceeding 15 million shares, far above its average. The price broke past both its 50-day and 200-day moving averages. Zacks upgraded the stock to Buy on Oct. 23, but overall analyst consensus remains Hold, with a 12-month price target averaging $4.03. Short interest stands at roughly 12.9% of float.
